Month: <span>April 2022</span>

Home / 2022 / April
Post

Researchers Continue to Unravel the Mystery of Metformin

Yale researchers have further elucidated the mechanism of metformin, a widely used type 2 diabetes medication that, despite its long history of being safe and effective, works in a way that has remained elusive to scientists. On March 1, Gerald Shulman, MD, PhD, George R. Cowgill Professor of Medicine (Endocrinology) and professor of cellular and molecular physiology, published his lab’s...

Post

Blood vessels are guides for stimulating implants

An implant little bigger than a grain of rice, but gently in place alongside a strategically placed blood vessel, could replace much bulkier devices that stimulate nerves. Rice University engineers in collaboration with a host of Texas Medical Center institutions have published the first proof-of-concept results from a year-long program to develop tiny, wireless devices that...

Post

The Retina as a Potential Biomarker for Reduced Brain Matter

Researchers from the Department of Ophthalmology at the University Hospital Bonn (UKB) and Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) have found a close connection between the dimensions of retinal structures and those of the brain. They report on this in the journal “Scientific Reports”. Their study results suggest that assessments of the eye’s retina could...

Post

New virology data shows the investigational COVID antiviral drug molnupiravir eliminates actively infectious SARS-CoV-2 virus by day 3 of starting therapy

EUROPEAN SOCIETY OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES New data to be presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2022, Lisbon, 23-26 April) shows that participants taking the new anti-COVID drug molnupiravir eliminate actively infectious SARS-CoV-2 virus by day 3 of starting therapy, while many participants who received placebo...

Post

New analysis of investigational COVID antiviral drug molnupiravir shows it appears to clear virus equally well in immunocompromised patients and those who are immunocompetent

EUROPEAN SOCIETY OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES A new analysis of data on the ‘COVID-19 pill’ molnupiravir shows it appears to clear active SARS-CoV-2 virus equally well in immunocompromised patients and those who are immunocompetent. The analysis, which will be presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2022,...

NTU Singapore researchers develop an efficient and precise motion capture system to aid in physiotherapy and athletics
Post

NTU Singapore researchers develop an efficient and precise motion capture system to aid in physiotherapy and athletics

NANYANG TECHNOLOGICAL UNIVERSITY IMAGE: THE NTU-DEVELOPED MOCAP TECHNOLOGY WOULD AID DOCTORS AND PHYSIOTHERAPISTS IN THEIR CONSULTATIONS AND DIAGNOSES FOR PATIENTS IN NEED OF REHABILITATION AFTER AN INJURY OR RECOVERING FROM AN ILLNESS. CREDIT: NTU SINGAPORE Singapore, 1st April 2022 NTU Singapore researchers develop an efficient and precise motion capture system to aid in physiotherapy and athletics ...

Post

Researchers investigate differences between post-stroke and post-surgery aphasia

NATIONAL RESEARCH UNIVERSITY HIGHER SCHOOL OF ECONOMICS Researchers from the HSE Centre for Language and Brain worked with Russian doctors to address the differences between the symptoms of post-stroke aphasia and aphasia caused by glioma surgery. Post-surgery patients demonstrate moderately severe speech disorders that impact all aspects of language processing simultaneously. Understanding these differences will help doctors...

What to know about bowel disorders
Post

What to know about bowel disorders

Medically reviewed by Kelsey Trull, PA-C — Written by Jamie Eske — Updated on March 22, 2022 Bowel disorders affect the organs in the digestive system, including the small and large intestines. They can prevent the body properly digesting and absorbing nutrients from food. This can cause symptoms such as diarrhea and constipation. Untreated, bowel...